Serina Therapeutics (SER) Operating Leases (2019 - 2026)
Serina Therapeutics (SER) posted Operating Leases of $377000.0 for Q4 2025, up 21.22% sequentially from $311000.0 in Q3 2025, and up 40.67% YoY from $268000.0 in Q4 2024.
Serina Therapeutics (SER) Operating Leases (2019 - 2026) Analysis & Trends
Serina Therapeutics has reported Operating Leases for 5 years, with the latest figure at $377000.0 in Q4 2025.
- Quarterly Operating Leases rose 40.67% year-over-year to $377000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $377000.0 (up 40.67% YoY) and the FY2025 annual result came in at $377000.0, up 40.67% from the prior year.
- Operating Leases advanced to $377000.0 in Q4 2025 per SER's latest filing, from $311000.0 in the prior quarter.
- Over five years, Operating Leases peaked at $675000.0 in Q4 2023 and troughed at $268000.0 in Q4 2024.
- A 3-year average of $409888.9 and a median of $377000.0 in 2025 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2024 and 2025: Operating Leases slumped 60.3% in 2024, then surged 40.67% in 2025.
- Over 3 years, Operating Leases stood at $675000.0 in 2023, then plunged by 60.3% to $268000.0 in 2024, then jumped by 40.67% to $377000.0 in 2025.
- According to Business Quant data, Operating Leases over the past three periods registered $377000.0, $311000.0, and $362000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - |
| 10 | Serina Therapeutics | 43.44 Mn | 20.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 122,000.00 |
| Dec 31, 2025 | 377,000.00 |
| Sep 30, 2025 | 311,000.00 |
| Jun 30, 2025 | 362,000.00 |
| Mar 31, 2025 | 412,000.00 |
| Dec 31, 2024 | 268,000.00 |
| Sep 30, 2024 | 509,000.00 |
| Jun 30, 2024 | 362,000.00 |
| Mar 31, 2024 | 413,000.00 |
| Dec 31, 2023 | 675,000.00 |
| Sep 30, 2020 | 109,000.00 |
| Mar 31, 2020 | 325,000.00 |
| Dec 31, 2019 | 428,000.00 |
| Sep 30, 2019 | 529,000.00 |
| Jun 30, 2019 | 628,000.00 |